IBDEI17G ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19576,0)
 ;;=I69.044^^67^877^66
 ;;^UTILITY(U,$J,358.3,19576,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19576,1,3,0)
 ;;=3^Monoplg low lmb fol ntrm subarach hemor aff left nondom side
 ;;^UTILITY(U,$J,358.3,19576,1,4,0)
 ;;=4^I69.044
 ;;^UTILITY(U,$J,358.3,19576,2)
 ;;=^5007407
 ;;^UTILITY(U,$J,358.3,19577,0)
 ;;=I69.841^^67^877^69
 ;;^UTILITY(U,$J,358.3,19577,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19577,1,3,0)
 ;;=3^Monoplg low lmb fol oth cerebvasc disease aff right dom side
 ;;^UTILITY(U,$J,358.3,19577,1,4,0)
 ;;=4^I69.841
 ;;^UTILITY(U,$J,358.3,19577,2)
 ;;=^5007532
 ;;^UTILITY(U,$J,358.3,19578,0)
 ;;=I69.842^^67^877^70
 ;;^UTILITY(U,$J,358.3,19578,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19578,1,3,0)
 ;;=3^Monoplg low lmb fol oth cerebvasc disease aff left dom side
 ;;^UTILITY(U,$J,358.3,19578,1,4,0)
 ;;=4^I69.842
 ;;^UTILITY(U,$J,358.3,19578,2)
 ;;=^5133577
 ;;^UTILITY(U,$J,358.3,19579,0)
 ;;=I69.843^^67^877^67
 ;;^UTILITY(U,$J,358.3,19579,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19579,1,3,0)
 ;;=3^Monoplg low lmb fol oth cerebvasc dis aff right nondom side
 ;;^UTILITY(U,$J,358.3,19579,1,4,0)
 ;;=4^I69.843
 ;;^UTILITY(U,$J,358.3,19579,2)
 ;;=^5007533
 ;;^UTILITY(U,$J,358.3,19580,0)
 ;;=I69.844^^67^877^68
 ;;^UTILITY(U,$J,358.3,19580,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19580,1,3,0)
 ;;=3^Monoplg low lmb fol oth cerebvasc dis aff left nondom side
 ;;^UTILITY(U,$J,358.3,19580,1,4,0)
 ;;=4^I69.844
 ;;^UTILITY(U,$J,358.3,19580,2)
 ;;=^5133578
 ;;^UTILITY(U,$J,358.3,19581,0)
 ;;=I69.241^^67^877^71
 ;;^UTILITY(U,$J,358.3,19581,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19581,1,3,0)
 ;;=3^Monoplg low lmb fol oth ntrm intcrn hemor aff right dom side
 ;;^UTILITY(U,$J,358.3,19581,1,4,0)
 ;;=4^I69.241
 ;;^UTILITY(U,$J,358.3,19581,2)
 ;;=^5007469
 ;;^UTILITY(U,$J,358.3,19582,0)
 ;;=I69.242^^67^877^72
 ;;^UTILITY(U,$J,358.3,19582,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19582,1,3,0)
 ;;=3^Monoplg low lmb fol oth ntrm intcrn hemor aff left dom side
 ;;^UTILITY(U,$J,358.3,19582,1,4,0)
 ;;=4^I69.242
 ;;^UTILITY(U,$J,358.3,19582,2)
 ;;=^5133574
 ;;^UTILITY(U,$J,358.3,19583,0)
 ;;=I69.243^^67^877^73
 ;;^UTILITY(U,$J,358.3,19583,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19583,1,3,0)
 ;;=3^Monoplg low lmb fol oth ntrm intcrn hemor aff r nondom side
 ;;^UTILITY(U,$J,358.3,19583,1,4,0)
 ;;=4^I69.243
 ;;^UTILITY(U,$J,358.3,19583,2)
 ;;=^5007470
 ;;^UTILITY(U,$J,358.3,19584,0)
 ;;=I69.244^^67^877^74
 ;;^UTILITY(U,$J,358.3,19584,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19584,1,3,0)
 ;;=3^Monoplg low lmb fol oth ntrm intcrn hemor aff l nondom side
 ;;^UTILITY(U,$J,358.3,19584,1,4,0)
 ;;=4^I69.244
 ;;^UTILITY(U,$J,358.3,19584,2)
 ;;=^5007471
 ;;^UTILITY(U,$J,358.3,19585,0)
 ;;=G35.^^67^877^75
 ;;^UTILITY(U,$J,358.3,19585,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19585,1,3,0)
 ;;=3^Multiple sclerosis
 ;;^UTILITY(U,$J,358.3,19585,1,4,0)
 ;;=4^G35.
 ;;^UTILITY(U,$J,358.3,19585,2)
 ;;=^79761
 ;;^UTILITY(U,$J,358.3,19586,0)
 ;;=G20.^^67^877^76
 ;;^UTILITY(U,$J,358.3,19586,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19586,1,3,0)
 ;;=3^Parkinson's disease
 ;;^UTILITY(U,$J,358.3,19586,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,19586,2)
 ;;=^5003770
 ;;^UTILITY(U,$J,358.3,19587,0)
 ;;=G21.4^^67^877^77
 ;;^UTILITY(U,$J,358.3,19587,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19587,1,3,0)
 ;;=3^Vascular parkinsonism
